SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech informs about outcome of board meeting

12 Sep 2022 Evaluate
Medicamen Biotech has informed that the Board of Directors of the Company, at their meeting held today, September 12, 2022 at 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi-110019h has considered and approved the following businesses: Allotment of 4,34,500 Equity Share for cash at an issue price of Rs 709 per Equity Share by way of preferential allotment;  Allotment of 63,500 Fully Convertible Warrants ('Warrants') each carrying a right to subscribe to one Equity Share per Warrant, for cash at an issue price of Rs 709 per warrant by way of preferential allotment.

The above information is a part of company’s filings submitted to BSE.


Medicamen Biotech Share Price

258.50 10.00 (4.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×